A detailed history of Gamma Investing LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 143 shares of AXGN stock, worth $2,581. This represents 0.0% of its overall portfolio holdings.

Number of Shares
143
Previous 103 38.83%
Holding current value
$2,581
Previous $1.44 Million 63.23%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025

BUY
$12.47 - $17.19 $498 - $687
40 Added 38.83%
143 $2.36 Million
Q3 2024

Oct 04, 2024

BUY
$7.52 - $14.69 $601 - $1,175
80 Added 347.83%
103 $1.44 Million
Q2 2024

Jul 02, 2024

BUY
$5.67 - $8.06 $130 - $185
23 New
23 $167,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $763M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.